Volpi E, Nazemi R, Fujita S (2004) Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care 7(4):405–410

CAS  PubMed Central  Google Scholar 

Volpato S et al (2014) Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol Biol Sci Med Sci 69(4):438–446

CAS  Google Scholar 

Buckinx F, Aubertin-Leheudre M (2022) Sarcopenia in menopausal women: current perspectives. Int J Womens Health 14:805–819

CAS  PubMed  PubMed Central  Google Scholar 

Tiidus PM, Lowe DA, Brown M (2013) Estrogen replacement and skeletal muscle: mechanisms and population health. J Appl Physiol (1985) 115(5):569–578

CAS  PubMed  Google Scholar 

Sipila S et al (2020) Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle 11(3):698–709

PubMed  PubMed Central  Google Scholar 

Anagnostis P et al (2022) Menopause-associated risk of cardiovascular disease. Endocr Connect, 11(4)

Angelou K et al (2020) The genitourinary syndrome of menopause: an overview of the recent data. Cureus 12(4):e7586

PubMed  PubMed Central  Google Scholar 

Jeong HG, Park H (2022) Metabolic Disorders Menopause Metabolites, 12(10)

Bondarev D et al (2021) Physical performance during the menopausal transition and the role of physical activity. J Gerontol Biol Sci Med Sci 76(9):1587–1590

Google Scholar 

Phu S et al (2020) The diagnostic value of the short physical performance battery for sarcopenia. BMC Geriatr 20(1):242

PubMed  PubMed Central  Google Scholar 

Silva CFR et al (2022) Short physical performance battery as a predictor of mortality in community-dwelling older adults: a longitudinal study in the Brazilian Amazon region. PeerJ 10:e13630

PubMed  PubMed Central  Google Scholar 

Gregorio L et al (2014) Adequate dietary protein is associated with better physical performance among post-menopausal women 60–90 years. J Nutr Health Aging 18(2):155–160

CAS  PubMed  PubMed Central  Google Scholar 

Zhao J et al (2023) Investigating association between gut microbiota and sarcopenia-related traits: a Mendelian randomization study. Precis Clin Med 6(2):pbad010

PubMed  PubMed Central  Google Scholar 

Shieh A et al (2020) Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight, 5(2)

Tang G et al (2022) Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K/Akt/mTOR signals. Br J Pharmacol 179(1):159–178

CAS  PubMed  Google Scholar 

Qaisar R et al (2024) Butyrate supplementation reduces sarcopenia by repairing neuromuscular junction in patients with chronic obstructive pulmonary disease. Respir Med 222:107510

PubMed  Google Scholar 

Banasiewicz T et al (2020) Determination of Butyric acid dosage based on clinical and experimental studies - a literature review. Prz Gastroenterol 15(2):119–125

CAS  PubMed  PubMed Central  Google Scholar 

Janssen I et al (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) 89(2):465–471

CAS  PubMed  Google Scholar 

World Medical A (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194

Google Scholar 

Sawaya Y et al (2022) Patterns of changes in respiratory muscle strength over 1 year in Non-Sarcopenia, sarcopenia, and severe sarcopenia. Int J Environ Res Public Health, 19(24)

Karim A et al (2021) Intestinal permeability marker Zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease. Respir Med 189:106662

PubMed  Google Scholar 

Qaisar R et al (2021) The coupling between sarcopenia and COVID-19 is the real problem. Eur J Intern Med 93:105–106

CAS  PubMed  PubMed Central  Google Scholar 

Arai H (2018) Sarcopenia diagnostic criteria update by EWGSOP: what has been changed? Eur Geriatr Med 9(6):733–734

PubMed  Google Scholar 

Karim A et al (2022) A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure. J Cardiol 80(5):449–455

PubMed  Google Scholar 

Qaisar R et al (2024) A leaky gut contributes to postural imbalance in male patients with chronic obstructive pulmonary disease. Clin Nutr ESPEN 62:157–163

PubMed  Google Scholar 

Qaisar R et al (2024) The association of intestinal leak with sarcopenia and physical disability in patients with various stages of chronic kidney disease. Calcif Tissue Int 115(2):132–141

CAS  PubMed  Google Scholar 

Sanz-Paris A et al (2018) Role of oral nutritional supplements enriched with beta-Hydroxy-beta-Methylbutyrate in maintaining muscle function and improving clinical outcomes in various clinical settings. J Nutr Health Aging 22(6):664–675

CAS  PubMed  PubMed Central  Google Scholar 

Bear DE et al (2019) beta-Hydroxy-beta-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice: a systematic review and meta-analysis. Am J Clin Nutr 109(4):1119–1132

PubMed  Google Scholar 

Phillips SM et al (2022) An umbrella review of systematic reviews of beta-hydroxy-beta-methyl butyrate supplementation in ageing and clinical practice. J Cachexia Sarcopenia Muscle 13(5):2265–2275

PubMed  PubMed Central  Google Scholar 

Harris-Love MO et al (2018) The influence of upper and lower extremity strength on Performance-Based sarcopenia assessment tests. J Funct Morphol Kinesiol, 3(4)

Fasano A (2020) All disease begins in the (leaky) Gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res:9

Ji Y et al (2022) Inflammation: roles in skeletal muscle atrophy. Antioxid (Basel), 11(9)

Li X, Ma L (2024) From biological aging to functional decline: insights into chronic inflammation and intrinsic capacity. Ageing Res Rev 93:102175

PubMed  Google Scholar 

Alamdari N et al (2012) Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness. Am J Physiol Regul Integr Comp Physiol 303(10):R1090–R1099

CAS  PubMed  PubMed Central  Google Scholar 

Hong J et al (2016) Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice. Oncotarget 7(35):56071–56082

PubMed  PubMed Central  Google Scholar 

Murray RL et al (2018) Dietary tributyrin, an HDAC inhibitor, promotes muscle growth through enhanced terminal differentiation of satellite cells. Physiol Rep 6(10):e13706

PubMed  PubMed Central  Google Scholar 

Liu H et al (2023) The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization. Int Immunopharmacol, 124(Pt B): p. 111001

Gao Z et al (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7):1509–1517

CAS  PubMed  PubMed Central  Google Scholar 

Mohamed Elfadil O et al (2023) Butyrate: more than a short chain fatty acid. Curr Nutr Rep 12(2):255–262

CAS  PubMed  Google Scholar 

Hodgkinson K et al (2023) Butyrate’s role in human health and the current progress towards its clinical application to treat Gastrointestinal disease. Clin Nutr 42(2):61–75

CAS  PubMed  Google Scholar 

Bach Knudsen KE et al (2018) Impact of Diet-Modulated butyrate production on intestinal barrier function and inflammation. Nutrients, 10(10)

Kim J, Baek Y, Lee S (2024) Consumption of dietary fiber and APOA5 genetic variants in metabolic syndrome: baseline data from the Korean medicine Daejeon citizen cohort study. Nutr Metab (Lond) 21(1):19

CAS  PubMed  Google Scholar 

Su H et al (2024) The effects of beta-hydroxy-beta-methylbutyrate or HMB-rich nutritional supplements on sarcopenia patients: a systematic review and meta-analysis. Front Med (Lausanne) 11:1348212

PubMed  Google Scholar